Document is current

Article History

Received: 16 June 2021

Revised: 6 October 2021

Accepted: 7 October 2021

First Online: 15 October 2021

Change Date: 21 February 2022

Change Type: Update

Change Details: The Funding information has been added.

Declarations

:

: The study was approved by the Ethics Review Authority in Sweden (Dnr 2020–00556). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study. The authors confirm that all patient/personal identifiers have been removed or disguised, so the patient/person(s) described cannot be identified through the details of the story.

: All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with the ICMJE criteria.

: Karin Schölin Bywall and Jennifer Viberg Johansson have no conflict of interest to declare. Bente Appel Esbensen have received speaking fees from Pfizer and Lilly.Marie Heidenvall and Inger Erlandsson are supported by the Swedish Rheumatism Association as patient research partners. Marta Larson is employed at ELSA Science.